Kymera Therapeutics, Inc. (KYMR)
81.74
+0.97
(+1.20%)
USD |
NASDAQ |
May 27, 16:00
81.74
0.00 (0.00%)
After-Hours: 16:33
Kymera Therapeutics Free Cash Flow : -244.00M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 10.23B |
| Revolution Medicines, Inc. | -1.072B |
| Celcuity, Inc. | -172.97M |
| Kodiak Sciences, Inc. | -148.12M |
| Tango Therapeutics, Inc. | -142.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -88.84M |
| Cash from Investing (Quarterly) | -142.84M |
| Cash from Financing (Quarterly) | 18.77M |
| Free Cash Flow Per Share (Quarterly) | -0.9153 |
| Free Cash Flow to Equity (Quarterly) | -87.49M |
| Free Cash Flow to Firm (Quarterly) | -89.21M |
| Free Cash Flow Yield | -3.36% |